This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lifton, R. P. Articles by Lalouel, J. M. Search for Related Content PubMed PubMed Citation Articles by Lifton, R. P. Articles by Lalouel, J. M. Pubmed/NCBI databases OMIM Medline Plus Health Information Genes and Gene Therapy High Blood Pressure

Hypertension, Vol 17, 8-14, Copyright © 1991 by American Heart Association

ARTICLES

Exclusion of the Na(+)-H+ antiporter as a candidate gene in human essential hypertension

RP Lifton, SC Hunt, RR Williams, J Pouyssegur and JM Lalouel
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

The primary abnormalities that contribute to the pathogenesis of human essential hypertension are unknown. The known genetic contribution to this disorder suggests the possible use of genetic linkage analysis to test whether specific candidate genes contribute to the pathogenesis of either essential hypertension or intermediate phenotypes. Among such phenotypes, elevated erythrocyte Na(+)-Li+ countertransport (SLC) is the best known, supporting major gene inheritance by pedigree analysis. Striking similarities between SLC and Na(+)-H+ exchange suggest that mutations at the Na(+)-H+ antiporter gene locus (APNH) might result in elevated SLC and contribute to the subsequent pathogenesis of hypertension. We have tested these hypotheses by genetic linkage analysis, with APNH as a candidate gene. By determining genotypes at APNH and flanking loci in pedigrees that support major gene segregation of elevated SLC, we have excluded linkage of APNH and the major SLC locus with a LOD score of -5.91, an odds ratio of almost 1,000,000:1 against linkage. In the analysis of 93 hypertensive sibling pairs, we have further demonstrated that APNH explains none of the variance in SLC in hypertensive individuals (r2 = 6 x 10(-7), p greater than 0.99). Finally, we have directly tested for linkage of APNH to genes predisposing toward hypertension by linkage in hypertensive sibling pairs. Mean allele sharing at APNH is not greater than expected from random assortment in hypertensive siblings (0.92 versus 1.0, p greater than 0.80), and the upper 95% confidence limit of this value (1.04) indicates that mutations at APNH rarely if ever contribute to the pathogenesis of hypertension in this population.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Xiang, M. Feng, S. Muend, and R. Rao A human Na+/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension PNAS, November 20, 2007; 104(47): 18677 - 18681. [Abstract] [Full Text] [PDF]

				O. Vaccaro, V. Cuomo, M. Trevisan, M. Cirillo, W. Panarelli, M. Laurenzi, M. Mancini, G. Riccardi, and On behalf of the Gubbio Study Research Group Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes Int. J. Epidemiol., October 1, 2005; 34(5): 1123 - 1128. [Abstract] [Full Text] [PDF]

				P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF]

				G. Zerbini, D. Gabellini, D. Ruggieri, and A. Maestroni Increased Sodium-Lithium Countertransport Activity: A Cellular Dysfunction Common to Essential Hypertension and Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S81 - 84. [Abstract] [Full Text]

				G. Zerbini, A. Maestroni, D. Breviario, R. Mangili, and G. Casari Alternative Splicing of NHE-1 Mediates Na-Li Countertransport and Associates With Activity Rate Diabetes, June 1, 2003; 52(6): 1511 - 1518. [Abstract] [Full Text] [PDF]

				A. B. Weder, M. C. Delgado, X. Zhu, L. Gleiberman, D. Kan, and A. Chakravarti Erythrocyte Sodium-Lithium Countertransport and Blood Pressure: A Genome-Wide Linkage Study Hypertension, March 1, 2003; 41(3): 842 - 846. [Abstract] [Full Text] [PDF]

				N. J. Schork, J. P. Gardner, L. Zhang, D. Fallin, B. Thiel, H. Jakubowski, and A. Aviv Genomic Association/Linkage of Sodium Lithium Countertransport in CEPH Pedigrees Hypertension, November 1, 2002; 40(5): 619 - 628. [Abstract] [Full Text] [PDF]

				J. Malakooti, R. Y. Dahdal, P. K. Dudeja, T. J. Layden, and K. Ramaswamy The human Na+/H+ exchanger NHE2 gene: genomic organization and promoter characterization Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G763 - G773. [Abstract] [Full Text] [PDF]

				E. Poch, D. Gonzalez, E. Gomez-Angelats, M. Enjuto, J. C. Pare, F. Rivera, and A. de la Sierra G-Protein {beta}3 Subunit Gene Variant and Left Ventricular Hypertrophy in Essential Hypertension Hypertension, January 1, 2000; 35(1): 214 - 218. [Abstract] [Full Text] [PDF]

				P. Mead, R. Wilkinson, and T. H. Thomas Thiol Protein Defect in Sodium-Lithium Countertransport in Subset of Essential Hypertension Hypertension, December 1, 1999; 34(6): 1275 - 1280. [Abstract] [Full Text] [PDF]

				S. N. Orlov, N. C. Adragna, V. A. Adarichev, and P. Hamet Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension Am J Physiol Cell Physiol, March 1, 1999; 276(3): C511 - C536. [Abstract] [Full Text] [PDF]

				S. N. Orlov, S. L. Aksentsev, N. I. Pokudin, J. Tremblay, and P. Hamet Na+/H+ Exchange in Vascular Smooth Muscle Cells Is Controlled by GTP-Binding Proteins Hypertension, January 1, 1998; 31(1): 259 - 265. [Abstract] [Full Text] [PDF]

				V. N. Phan, M. Kusuhara, P. A. Lucchesi, and B. C. Berk A 90-kD Na+-H+ Exchanger Kinase Has Increased Activity in Spontaneously Hypertensive Rat Vascular Smooth Muscle Cells Hypertension, June 1, 1997; 29(6): 1265 - 1272. [Abstract] [Full Text]

				L. M. Brzustowicz, J. P. Gardner, L. Hopp, E. Jeanclos, J. Ott, X. Y. Yang, Z. Fekete, and A. Aviv Linkage Analysis Using Platelet-Activating Factor Ca2+ Response in Transformed Lymphoblasts Hypertension, January 1, 1997; 29(1): 158 - 164. [Abstract] [Full Text] [PDF]

				W. Siffert and R. Dusing Sodium-Proton Exchange and Primary Hypertension : An Update Hypertension, October 1, 1995; 26(4): 649 - 655. [Abstract] [Full Text]

				M. Siczkowski, J. E. Davies, and L. L. Ng Na+-H+ Exchanger Isoform 1 Phosphorylation in Normal Wistar-Kyoto andSpontaneously Hypertensive Rats Circ. Res., May 1, 1995; 76(5): 825 - 831. [Abstract] [Full Text]

				J. P. Reeves and A. Aviv Na+-H+ Exchange and Essential Hypertension : A New Approach Hypertension, May 1, 1995; 25(5): 978 - 980. [Full Text]

				S. Lehoux, J.-i. Abe, J. A. Florian, and B. C. Berk 14-3-3 Binding to Na+/H+ Exchanger Isoform-1 Is Associated with Serum-dependent Activation of Na+/H+ Exchange J. Biol. Chem., May 4, 2001; 276(19): 15794 - 15800. [Abstract] [Full Text] [PDF]